long term side effects glp 1 Comparing GLP‑1 Drugs With Other Weight Loss Methods: Diet & Exercise, Bariatric Surgery, and Lifestyle Programs -Pros & Cons GLP-1 use has unhealthy long

2023 data have shown that pharmaceutical companies have spent over $1 billion on advertisements for weight loss and diabetes medications, which is up 51% from the previous year

dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

Inflammation can also produce free radicals

For oral/IV use only

It improved endothelial function and reduced mROS production in an in vivo model of hypertension [109], and modified the inflammatory profile of endothelial cells treated with preeclampsia plasma

We are committed to providing our patients with the most advanced options for supporting healthy weight loss